Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liam R Brunham

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Head & Neck|February 17, 2018
Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian populationSze Ling Chan, Li Shia Ng, Xueying Goh, et al.
American Journal of Medical Genetics. Part A|September 24, 2004
A case of Tangier disease with a novel mutation in the C-terminal region of ATP-binding cassette transporter A1Jing-Zhi Guan, Naoki Tamasawa, Liam R Brunham, et al.
American Journal of Preventive Cardiology|July 30, 2024
Cardiovascular risk and subclinical atherosclerosis in first-degree relatives of patients with premature cardiovascular diseaseDiana N Vikulova, Danielle Pinheiro-Muller, Gordon Francis, et al.
Scientific Reports|May 5, 2016
Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-CardiomyocytesAgnes Maillet, Kim Tan, Xiaoran Chai, et al.
Plos One|October 17, 2017
Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patientsSze Ling Chan, Angeline Poh Gek Chua, Folefac Aminkeng, et al.
The Canadian Journal of Cardiology|December 18, 2025
Canadian Cardiovascular Society Clinical Practice Update on Cardiogenetic TestingMelanie Care, Laura Arbour, Liam R Brunham, et al.
Thyroid : Official Journal of the American Thyroid Association|June 29, 2010
The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacologyColin J D Ross, Henk Visscher, Johanna Sistonen, et al.
Pharmacogenetics and Genomics|October 8, 2015
Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomicsSze Ling Chan, Nilakshi Samaranayake, Colin J D Ross, et al.
Circulation Research|July 29, 2006
Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitroRoshni R Singaraja, Henk Visscher, Erick R James, et al.
Journal of the American College of Cardiology|July 27, 2019
Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial HypercholesterolemiaMark Trinder, Xuan Li, Maria Liza DeCastro, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Head & Neck|February 17, 2018
Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian populationSze Ling Chan, Li Shia Ng, Xueying Goh, et al.
American Journal of Medical Genetics. Part A|September 24, 2004
A case of Tangier disease with a novel mutation in the C-terminal region of ATP-binding cassette transporter A1Jing-Zhi Guan, Naoki Tamasawa, Liam R Brunham, et al.
American Journal of Preventive Cardiology|July 30, 2024
Cardiovascular risk and subclinical atherosclerosis in first-degree relatives of patients with premature cardiovascular diseaseDiana N Vikulova, Danielle Pinheiro-Muller, Gordon Francis, et al.
Scientific Reports|May 5, 2016
Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-CardiomyocytesAgnes Maillet, Kim Tan, Xiaoran Chai, et al.
Plos One|October 17, 2017
Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patientsSze Ling Chan, Angeline Poh Gek Chua, Folefac Aminkeng, et al.
The Canadian Journal of Cardiology|December 18, 2025
Canadian Cardiovascular Society Clinical Practice Update on Cardiogenetic TestingMelanie Care, Laura Arbour, Liam R Brunham, et al.
Thyroid : Official Journal of the American Thyroid Association|June 29, 2010
The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacologyColin J D Ross, Henk Visscher, Johanna Sistonen, et al.
Pharmacogenetics and Genomics|October 8, 2015
Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomicsSze Ling Chan, Nilakshi Samaranayake, Colin J D Ross, et al.
Circulation Research|July 29, 2006
Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitroRoshni R Singaraja, Henk Visscher, Erick R James, et al.
Journal of the American College of Cardiology|July 27, 2019
Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial HypercholesterolemiaMark Trinder, Xuan Li, Maria Liza DeCastro, et al.
Pageof 16